Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells
DE10319837A1
Preventing or treating inner ear diseases, e.g. due to ototoxic medicaments, by administration of noble gas selected from argon, xenon, krypton, helium and/or neon
DE10315654A1
8-nitro-tryptanthrin and other tryptanthrin derivatives for the treatment of diseases caused by highly proliferating cells
EP1398372A1
Lipid phosphate phosphatases and uses thereof for treating neuronal diseases
DE10258483B3
Optical biopsy instrument for extracting breast tissue sample from milk duct having endoscope displaced within cylindrical channel having side opening with cutting edge
DE10256669A1
Mixture of at least two fusion proteins and their preparation and use
WO03048166A1
Podophyllotoxins as antiproliferative agents
WO03037920A2
Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
DE10238922A1
Immune markers for diagnosis and therapy in connection with graft reactions
DE10234200A1
Use of regulatory CD25 positive T cells for modulating inflammatory responses, for treating transplant rejection, autoimmune diseases and tumors
DE10233958A1
Restriction endonucleases, process for their preparation and their use
DE10232697A1
Use of CD152 for the treatment of autoimmune diseases and inflammation
EP1376134A1
A method of screening for TRAIL-inhibitors
DE10225174A1
Virtual microscope device and method
DE10221839A1
Method and apparatus for automatically detecting motor restlessness of a subject
DE10219298A1
New chicken antibodies against prion proteins, useful for diagnosis of transmissible, specifically bovine, spongiform encephalopathy
DE10217035A1
Recruiting modules for proteins RhoA and RhoC, useful e.g. in treatment of melanoma or breast cancer, and for targeted delivery of proteins to membranes
DE10212572A1
Bone formation controlling composition, especially for treatment of osteoporosis, containing ANK-pyrophosphate channel modulator, e.g. human ANK gene variant or probenecid
DE10209072A1
Composition for reducing body weight, useful for treating obesity, comprises beta-melanocyte-stimulating hormone peptide
